Certainly, the targeting of OLIG2 is feasible for gliomas in adults, but it should be noted that the degree of expression can vary in glioblastomas and astrocytoma while it is usually well expressed in oligodendrogliomas (325). Here, OLIG2 is linked to central nervous system cancer.